A Canadian citizen was sentenced to 48 months in prison today for his role in a scheme to defraud consumers purchasing pharmaceuticals online, the Justice Department announced. Andrew J. Strempler was also ordered to pay a forfeiture of $300,000, a fine of $25,000 and restitution.

New Jersey-based Par Pharmaceutical Companies Inc. pleaded guilty in federal court today and agreed to pay $45 million to resolve its criminal and civil liability in the company’s promotion of its prescription drug Megace ES for uses not approved as safe and effective by the Food and Drug Administration and not covered by federal health care programs.

Teva Pharmaceuticals USA Inc. has agreed to pay a $2.25 million civil penalty to settle alleged violations of the federal Clean Air Act (CAA), Clean Water Act (CWA), and the Resource Conservation and Recovery Act (RCRA), as well as the Missouri Air Conservation Law, Clean Water Law and Hazardous Waste Management Law at its facility in Mexico, Mo.

The Justice Department announced today that the United States has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp. involving alleged kickbacks paid by the company to health care providers.

Pharmaceutical company ISTA Pharmaceuticals, Inc. pled guilty earlier today to conspiracy to introduce a misbranded drug into interstate commerce and conspiracy to pay illegal remuneration in violation of the Federal Anti-Kickback Statute.

King Pharmaceuticals LLC (King) will pay $2.2 million and take measures to comply with the Clean Air Act to resolve alleged violations of the Clean Air Act (CAA) at its pharmaceutical manufacturing facility located in Bristol, Tenn.

Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer, Inc. in 2009, has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration (FDA).

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration.

A Wisconsin pharmacist and a Nevada pharmacologist were arraigned on an indictment today in Federal Court in Central Islip, New York, before United States Magistrate Judge Gary Brown. The defendants are charged with conspiring to supply at least four million misbranded and counterfeit pharmaceuticals to an illegal Internet pharmacy based in Costa Rica that catered to U.S. customers.

From : Communities>>Regulatory Open Forum
Hi everyone, As currently drafted,  the 2020 Chinese Pharmacopeia, the benchmark publication on the safety and efficacy of pharmaceuticals legally available in China, includes 319 new entries. The publication includes more than 5,500 traditional Chinese and Western medicines. The official compendium of the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug legally marketed in China is published by the Chinese Pharmacopoeia Commission. It is designed [More]

Current water treatment can't remove these wastes that are increasingly implicated in serious environmental effects

Ask About the Curve Public Service Announcement

The Park Family’s Infertility Story

Ask About the Curve Public Service Announcement

Kare Schultz, CEO of Teva Pharmaceuticals, joins "Squawk on the Street" to discuss the coronavirus pandemic and treatment.

Exports of Pharmaceuticals in France increased to 3874 EUR Million in March from 2668 EUR Million in February of 2020. Exports of Pharmaceuticals in France averaged 2022.39 EUR Million from 2000 until 2020, reaching an all time high of 3874 EUR Million in March of 2020 and a record low of 918 EUR Million in April of 2000. This page includes a chart with historical data for France Export: Pharmaceuticals.

Exports - Pharmaceuticals, Vitamin, Diagnostic Product in Switzerland increased to 10314.12 CHF Million in March from 7828.12 CHF Million in February of 2020. Exports - Pharmaceuticals, Vitamin, Diagnostic Pro in Switzerland averaged 6977.56 CHF Million from 2014 until 2020, reaching an all time high of 10314.12 CHF Million in March of 2020 and a record low of 4831.40 CHF Million in December of 2014. This page includes a chart with historical data for Switzerland Exports of Pharmaceuticals, Vitamin, Diagnostic P.

Imports of Pharmaceuticals in China decreased to 3138000 USD THO in April from 3840100 USD THO in March of 2020. Imports of Pharmaceuticals in China averaged 2209862.09 USD THO from 2014 until 2020, reaching an all time high of 5043700 USD THO in February of 2020 and a record low of 1078115 USD THO in February of 2015. This page includes a chart with historical data for China Imports of Pharmaceuticals.

While human travel has become severely restricted in recent months, the movement of goods has remained a constant priority — and in some cases, has become even more urgent. Today, a startup out of Switzerland that builds hardware and operates a logistics network designed to transport one item in particular — pharmaceuticals — is announcing […]

Dexter Blackstock has gone from football to pharmaceuticals - and hopes to save lives, slash the cost of healthcare and even help change the perception of professional players.

Hefferon, Kathleen L

Berlin ; New York : Springer-Verlag, [2005]

Dewey Library - RM301.3.S48 G46 2017

Online Resource

Marketline

Marketline

Online Resource

Online Resource

A senior government official said Cadila Pharmaceuticals closed its Ahmedabad plant as five employees tested positive last week, and 21 this week.

Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of The High Cost of Prescription Drugs in the United States from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals.

Also see The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions by Thomas A. Abbott and John A. Vernon.

Online Resource

Aggressive capex, manufacturing capabilities for US and a change in domestic strategy make the stock attractive